In summary, the inhibition of Stat5 by IST5-002 reduced AR-FL and AR-V mRNA levels in both androgen-sensitive and castrate-resistant CWR22Pc tumors, which was accompanied by decreased CRPC tumor growth. The gene discussed is STAT5A; the disease is neoplasm.